We conducted the present case-control study to investigate the association between two polymorphisms at ERCC1 (118 and 8092) with some clinicopathological features of NSCLC patients such as age, gender, TNM stage, response to therapy and smoking status in the Markazi province of Iran. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.